Areas of Focus
- Clinical multicenter RCT and cohort studies on cerebrovascular diseases
- Proteomics and molecular mechanism research of cerebrovascular diseases
- Artificial intelligence twin digital research of cerebrovascular interventional technology
Work Experience
- 2008/07 - Present - University of Science and Technology of China First Affiliated Hospital (Anhui Provincial Hospital) - Chief Physician, Special Researcher
Academic Background & Achievements
- 1999/09 - 2003/06 Bachelor's in Clinical Medicine: Anhui Medical University
- 2006/09 - 2008/06 Master's in Neurology: Southern Medical University, Supervisor: Liu Xinfeng
- 2014/09 - 2017/12 Doctorate in Neurology: Anhui Medical University, Supervisor: Wang Kai
- Outstanding Research Principal Award, University of Science and Technology of China, 2022
Publications
- ATTENTION Investigators. Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion., Wei Hu, 2022
- Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry., Wei Hu, 2022
- Elabela-APJ axis attenuates cerebral ischemia/reperfusion injury by inhibiting neuronal ferroptosis., Wei Hu, 2023
- Effect of renal impairment on the efficacy and safety of intra-arterial treatment: A post-hoc analysis of DIRECT-MT study., Wei Hu, 2022
- Endovascular treatment for acute basilar artery occlusion: A multicenter randomized controlled trial (ATTENTION)., Wei Hu, 2022
- TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage., Wei Hu, 2021
- STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke., Wei Hu, 2023
- Effect of routine inflammatory markers on clinical outcomes in acute basilar artery occlusion after endovascular thrombectomy: Results from ATTENTION registry., Wei Hu, 2023
Awards
- Anhui Science and Technology Award (2022): Second Prize
- Outstanding Research Principal Award (2023): University of Science and Technology of China